Skip to main content

Tower Research Capital LLC (TRC)

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$73,259
+$33,106 QoQ
Shares Held
52,705
+111.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $6,212,926 across 59 Drug Manufacturers - Specialty & Generic names. AKBA ranks #19 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $73,259 52,705
2025-12-31 $40,153 24,940
2025-09-30 $55,230 20,231
2025-06-30 $83,072 22,822
2025-03-31 $12,071 6,287
2024-12-31 $14,942 7,865
2024-09-30 $11,966 9,066
2024-06-30 $2,747 2,694
2024-03-31 $63,404 34,647
2023-12-31 $2,112 1,704
2023-09-30 $1,339 1,175
2023-06-30 $9,030 9,869
2023-03-31 $13 22,896
2022-12-31 $10 17,211
2022-09-30 $11,951 37,823
2022-06-30 $13,919 39,433
2022-03-31 $40,967 57,058
2021-12-31 $175,786 77,782
2021-09-30 $95,065 33,009
2021-06-30 $60,135 15,867
2021-03-31 $70,421 20,804
2020-12-31 $38,687 13,817
2020-09-30 $422,483 168,320
2020-06-30 $379,343 27,934
2020-03-31 $758 100